An hour may change everything for patients with lumbar spinal stenosis (LSS). Find out how this minimally invasive, outpatient procedure, which has a safety profile similar to an epidural steroid injection (ESI), may help you stand longer and walk farther with less pain.
Learn More
Pain or numbness in lower back when standing
Pain, numbness or tingling in legs or buttocks when walking
Relief when sitting or leaning forward
Help your LSS patients, even those with comorbidities, by removing a major root cause of their neurogenic claudication. Move to mild® to provide patients with long-term relief using a therapy that has a safety profile equivalent to an ESI, but with lasting results. Learn more about the minimally invasive mild® Procedure’s key benefits, clinical outcomes and how it can be incorporated into your treatment algorithm.
Learn MoreAdvanced Practice Providers (APPs) are a vital part of care delivery for patients with chronic pain associated with lumbar spinal stenosis (#LSS). Do you manage patient identification and education? Are you able to identify Mild candidates?
Our practice resources, including diagnostic reference sheets, patient education tools, and more, are designed to help you identify, communicate with, and support patients looking to improve their mobility and pain. Read on at the #linkinbio and contact your Vertos representative to learn more.
In the Interventional Pain community, building relationships with referring clinicians, many of whom are unfamiliar with minimally invasive lumbar decompression, can help better serve patients with lumbar spinal stenosis (#LSS). Educate colleagues on the services you provide and how you not only help manage symptoms, but also restore function, improve overall health, and enhance patients' quality of life.
In his recent blog, Dr. @davedickersonMD shares actionable tips on how to build a referral network around the treatment of patients with pain and mobility issues associated with #LSS. Read the full blog at the #linkinbio.
Spotlight: The New Mild Patient Brochure
Help your lumbar spinal stenosis (#LSS) patients learn more about their condition and the Mild Procedure with our new patient brochure! This resource allows you to demonstrate the anatomical effects of LSS, educate on how Mild is different from other LSS treatment options, and help patients prepare for their treatment.
Reach out to a Vertos Medical representative for more information on the new practice materials.
New Year, New Mild Resources! Looking for new ways to educate your community, drive meaningful engagement, and help more patients get back on their feet?
As we kick off 2022, Vertos Medical is proud to offer our providers brand new Mild Procedure practice resources, including updated patient education, healthcare professional, and digital (website/social media) tools that help you serve your community.
Get your practice outfitted with the latest resources and help more patients #MOVE2mild today. Reach out to your Vertos representative for more information!
Watch our video to learn how your practice can get the most impact from Mild at the #linkinbio.
Are you an Advanced Practice Provider (APP) in Interventional Pain Management? We are pleased to offer APP-focused events and education. Connect with us at the #linkinbio to learn more about opportunities to engage with your peers, access tips & resources, and to stay informed on the latest news about the Mild Procedure.
Make the #MOVE2mild to help your lumbar spinal stenosis (#LSS) patients find lasting relief.
Epidural steroid injections (ESIs)–a procedure in which medication is injected in the lower spine to reduce swelling and pain–are typically offered to lumbar spinal stenosis (#LSS) patients when more conservative methods like exercise and physical therapy have failed to provide relief. However, ESIs only treat the symptoms of LSS and do not address a major root cause of the problem.
The Mild Procedure addresses LSS by removing excess ligament tissue to restore space in the spinal canal.
Get your patients on the path to relief with Mild–the only treatment with a safety profile equivalent to an ESI, and the lasting relief expected from back surgery.*
*Clinical data at the #linkinbio.
Thank you to all the Advanced Practice Providers (APPs) who attended the Vertos Medical APP Symposium at the @aspn_painneuro Conference. APPs from across the country were able to share their experience and knowledge on the Mild Procedure and how it can help lumbar spinal stenosis (#LSS) patients find lasting relief.
Special thanks to Jane Hartigan, PA, Zohra Hussaini, NP, and Marie Zambelli, NP for their contributions and help making the APP Symposium such a success.
Interested in APP-focused education and events? Sign up at the #linkinbio to stay informed and receive the latest updates.
Mild made a major impact during the @aspn_painneuro Innovation Summit in Las Vegas and we couldn’t have done it without the leadership of many outstanding physicians and Advanced Practice Providers (APPs). Thank you to both Drs. @timdeer30a and Peter Staats for presenting sneak peeks of new #MildProcedure data. We’re looking forward to this important data being published soon.
More thanks to the spectacular group of proctors who spent the day coaching HUNDREDS of physicians on Mild Procedure best practices and procedural techniques. If you’re interested in attending an upcoming training, please click the #linkinbio.
We’re beyond inspired to see so many leading physicians and APPs in the Interventional Pain community coming together to help make Mild the gold standard of care for lumbar spinal stenosis (#LSS) patients.
New year, new treatment options! Make the #MOVE2mild this year to help your patients find lasting relief from lumbar spinal stenosis (#LSS) pain.
Our team is looking forward to another year of advancing care for the #LSS community with the Mild Procedure.
Data supports a different approach to lumbar spinal stenosis (#LSS) treatment algorithms that traditionally rely on serial epidural steroid injections (ESIs) to relieve chronic lower back and leg pain associated with neurogenic claudication. A recent study performed by Dr. @anjumbux and colleagues shows that performing the Mild Procedure immediately upon diagnosis of LSS or moving to Mild after the first ESI fails may help patients find lasting relief, and avoid "ESI Exhaustion."
Read on to learn Dr. Bux's insights on how to identify the signs of ESI Exhaustion and why to #MOVE2mild as a durable treatment option for LSS relief.
View the full blog at the #linkinbio.
Attention Advanced Practice Providers (APPs): Attending the @aspn_painneuro Innovation Summit in January? Please join us to learn more about the Mild Procedure and get to know other APPs from across the country.
We hope to see you there! Register at the #linkinbio.
This holiday season, we hope that every physician, Advanced Practice Provider (APP), and Mild patient can enjoy time with loved ones and celebrate cherished traditions.
From all of us at Vertos Medical, we wish you very happy holidays.
We are thrilled to welcome these new faces to Team Vertos. Their talent and wealth of experience will help expand access to the #MildProcedure throughout the U.S. so even more patients may find lasting relief from lumbar spinal stenosis (#LSS).
Please share a warm welcome with our new District Sales Managers, Justin Samuels and Eric Funderburk, District Sales Specialist, Alyssa Frankenfield, and Customer Service Representative, Jacqueline Lalor.
Interested in joining our team? Click the #linkinbio for employment opportunities.
As the Mild Procedure for lumbar spinal stenosis (#LSS) has gained more and more momentum—demonstrating a safety profile equivalent to epidural steroid injections, positive patient outcomes, and 5-year durability*—practices are making the #MOVE2mild a cornerstone of their LSS treatment algorithm.
Read the new blog by Dr. @organicstrings to learn why Mild is not only a durable treatment option for LSS patients, but also a great way to differentiate your offering and attract more referrals from the community.
*View clinical data and read the full blog at the #linkinbio.
Is this a Mild Procedure candidate?
Case History: 68 year-old male with worsening pain in left lower back, buttock, and leg. A full course of physical therapy, chiropractic care, and epidural injections was completed with little improvement. The patient showed no response to medication. He reported back pain of a 6-7 out of 10 at rest, escalating to 9-10 out of 10 when standing or walking. The patient was unable to stand or walk for more than 5 minutes, but found relief from sitting or forward flexion.
Answer: Yes! The featured patient was an excellent Mild candidate who achieved significant improvement in quality of life and mobility. By his two-week follow-up, his standing time increased to over 30 minutes and he achieved an impressive 8-point pain reduction down to 1 out of 10. He met his quality of life goals, including walking to the mailbox, gardening, and playing with his grandchildren.
Read the full case study at the #linkinbio.
Benyamin RM, Staats PS, MiDAS ENCORE Investigators. mild® is an effective treatment for lumbar spinal stenosis with neurogenic claudication: MiDAS ENCORE Randomized Controlled Trial. Pain Physician. 2016;19(4):229-242.
Mekhail N, Costandi S, Abraham B, Samuel SW. Functional and patient-reported outcomes in symptomatic lumbar spinal stenosis following percutaneous decompression. Pain Pract. 2012;12(6):417-425. doi:10.1111/j.1533-2500.2012.00565.x.
2012 data from Health Market Sciences report for Vertos Medical 2013.
Data on file with Vertos Medical.
Staats PS, Chafin TB, Golvac S, et al. Long-term safety and efficacy of minimally invasive lumbar decompression procedure for the treatment of lumbar spinal stenosis with neurogenic claudication: 2-year results of MiDAS ENCORE. Reg Anesth Pain Med. 2018;43:789-794. doi:10.1097/AAP.0000000000000868.
Based on mild® Procedure data collected in all clinical studies. Major complications are defined as dural tear and blood loss requiring transfusion.
MiDAS ENCORE responder data. On file with Vertos Medical.
Jain S, Deer TR, Sayed D, et al. Minimally invasive lumbar decompression: a review of indications, techniques, efficacy and safety. Pain Manag. 2020;10(5). https://doi.org/10.2217/pmt-2020-0037. Accessed June 1, 2020.
Deer TR, Grider JS, Pope JE, et al. The MIST Guidelines: the Lumbar Spinal Stenosis Consensus Group guidelines for minimally invasive spine treatment. Pain Pract. 2019;19(3)250-274. doi:10.1111/papr.12744.
Hansson T, Suzuki N, Hebelka H, Gaulitz A. The narrowing of the lumbar spinal canal during loaded MRI: the effects of the disc and ligamentum flavum. Eur Spine J. 2009;18(5):679-686. doi:10.1007/s00586-009-0919-7.
Treatment options shown are commonly offered once conservative therapies (e.g., physical therapy, pain medications, chiropractic) are not providing adequate relief. This is not intended to be a complete list of all treatments available. Doctors typically recommend treatments based on their safety profile, typically prioritizing low risk/less aggressive procedures before higher risk/more aggressive procedures, but will determine which treatments are appropriate for their patients.
Although the complication rate for the mild® Procedure is low, as with most surgical procedures, serious adverse events, some of which can be fatal, can occur, including heart attack, cardiac arrest (heart stops beating), stroke, and embolism (blood or fat that migrates to the lungs or heart). Other risks include infection and bleeding, spinal cord and nerve injury that can, in rare instances, cause paralysis. This procedure is not for everyone. Physicians should discuss potential risks with patients. For complete information regarding indications for use, warnings, precautions, and methods of use, please reference the devices’ Instructions for Use.
Patient stories on this website reflect the results experienced by individuals who have undergone the mild® Procedure. Patients are not compensated for their testimonial. The mild® Procedure is intended to treat lumbar spinal stenosis (LSS) caused by ligamentum flavum hypertrophy. Although patients may experience relief from the procedure, individual results may vary. Individuals may have symptoms persist or evolve or other conditions that require ongoing medication or additional treatments. Please consult with your doctor to determine if this procedure is right for you.
Reimbursement, especially coding, is dynamic and changes every year. Laws and regulations involving reimbursement are also complex and change frequently. Providers are responsible for determining medical necessity and reporting the codes that accurately describe the work that is done and the products and procedures that are furnished to patients. For this reason, Vertos Medical strongly recommends that you consult with your payers, your specialty society, or the AMA CPT regarding coding, coverage and payment.
Vertos Medical cannot guarantee coding, coverage, or payment for products or procedures. View our Billing Guide.
Vertos is an equal employment opportunity workplace committed to pursuing and hiring a diverse workforce. We strive to grow our team with highly skilled people who share our culture and values. All qualified applicants will receive consideration for employment without regard to sex, age, color, race, religion, marital status, national origin, ancestry, sexual orientation, gender identity, physical & mental disability, medical condition, genetic information, veteran status, or any other basis protected by federal, state or local law.
Hall S, Bartleson JD, Onofrio BM, Baker HL Jr, Okazaki H, O’Duffy JD. Lumbar spinal stenosis. Clinical features, diagnostic procedures, and results of surgical treatment in 68 patients. Ann Intern Med. 1985;103(2):271-275. doi:10.7326/0003-4819-103-2-271.
Kalichman L, Cole R, Kim DH, et al. Spinal stenosis prevalence & association with symptoms: The Framingham Study. Spine J. 2009;9(7):545-550. doi:10.1016/j.spinee.2009.03.005.
Fukusaki M, Kobayashi I, Hara T, Sumikawa K. Symptoms of spinal stenosis do not improve after epidural steroid injection. Clin J Pain. 1998;14(2):148-151. doi:10.1097/00002508-199806000-00010.
Mekhail N, Costandi S, Nageeb G, Ekladios C, Saied O. The durability of minimally invasive lumbar decompression procedure in patients with symptomatic lumbar spinal stenosis: Long-term follow-up [published online ahead of print, 2021 May 4]. Pain Pract. 2021;10.1111/papr.13020. doi:10.1111/papr.13020
Friedly JL, Comstock BA, Turner JA, et al. Long-Term Effects of Repeated Injections of Local Anesthetic With or Without Corticosteroid for Lumbar Spinal Stenosis: A Randomized Trial. Arch Phys Med Rehabil. 2017;98(8):1499-1507.e2. doi:10.1016/j.apmr.2017.02.029
Pope J, Deer TR, Falowski SM. A retrospective, single-center, quantitative analysis of adverse events in patients undergoing spinal stenosis with neurogenic claudication using a novel percutaneous direct lumbar decompression strategy. J Pain Res. 2021;14:1909-1913. doi: 10.2147/JPR.S304997
Pryzbylkowski P, Bux A, Chandwani K, et al. Minimally invasive direct decompression for lumbar spinal stenosis: impact of multiple prior epidural steroid injections [published online ahead of print, 2021 Aug 4]. Pain Manag. 2021;10.2217/pmt-2021-0056. doi:10.2217/pmt-2021-0056
Abstract presented at: American Society of Pain and Neuroscience Annual Conference; July 22-25, 2021; Miami Beach, FL.
